Literature DB >> 31588620

Ablation index-guided 50 W ablation for pulmonary vein isolation in patients with atrial fibrillation: Procedural data, lesion analysis, and initial results from the FAFA AI High Power Study.

Shaojie Chen1,2, Boris Schmidt1,2, Stefano Bordignon1,2, Lukas Urbanek1,2, Shota Tohoku1,2, Fabrizio Bologna1,2, Lazar Angelkov3, Iskren Garvanski3, Nikolaos Tsianakas1,2, Athanasios Konstantinou1,2, Luca Trolese1,2, Felix Weise1,2, Laura Perrotta1,2, K R Julian Chun1,2.   

Abstract

BACKGROUND: Radiofrequency high-power ablation appears to be a novel concept for atrial fibrillation (AF). The ablation index (AI) value has been associated with durability of pulmonary vein isolation (PVI).
OBJECTIVES: This study aimed to report the procedural data and initial results of a combined ablation technique using AI-guided high-power (AI-HP; 50 W) ablation for PVI.
METHODS: Symptomatic AF patients were consecutively enrolled and underwent wide-area contiguous circumferential PVI. Contact-force catheters were used, ablation power was set to 50 W targeting AI values (550 anterior and 400 posterior). Esophageal temperature was monitored during procedure, all patients underwent postablation esophageal endoscopy.
RESULTS: PVI was achieved in all (n = 50, mean age: 68 ± 9 years, female: 60%) patients, rate of first-round PVI was 92%. A total of N = 2105 AI-guided ablation lesions were analyzed. Comparing left anterior wall vs left posterior wall and right anterior wall vs right posterior wall, mean ablation time (s) per lesion was 20.5 ± 8 vs 8.6 ± 3 and 12.2 ± 4 vs 9.3 ± 3; mean contact force (g): 17.1 ± 12 vs 25.4 ± 14 and 33.7 ± 13 vs 21.0 ± 11; mean AI: 547 ± 48 vs 445 ± 55 and 555 ± 56 vs 440 ± 47 (all P < .0001). Procedure and fluoroscopy time (minute) were 55.6 ± 6.6 and 6 ± 1.7, respectively. Only one (2%) patient had a minimal esophageal lesion. During In-hospital and 1-month follow-up no major complications such as death, stroke, tamponade, or atriaesophageal fistula (AE) occurred. Preliminary 6-month follow-up showed 48 of 50 (96%) patients were free from clinical AF/atrial tachycardia recurrence.
CONCLUSION: AI-HP (50 W) ablation appears to be a feasible, safe, fast, and effective ablation technique for PVI.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  ablation; ablation index; atrial fibrillation; high power; pulmonary vein isolation

Year:  2019        PMID: 31588620     DOI: 10.1111/jce.14219

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  17 in total

1.  [Pulmonary vein isolation using radiofrequency ablation].

Authors:  Leon Iden; Sonia Busch; Daniel Steven; Roland R Tilz; Dong-In Shin; K R Julian Chun; Heidi Estner; Felix Bourier; David Duncker; Philipp Sommer; Andreas Metzner; Tilman Maurer; Nils-Christian Ewertsen; Henning Jansen; Andreas Rillig; Victoria Johnson; Till Althoff
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-07-26

2.  Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation.

Authors:  Dibbendhu Khanra; Abdul Hamid; Saurabh Deshpande; Anindya Mukherjee; Sanjiv Petkar; Mohammad Saeed; Indranill Basu-Ray
Journal:  Anatol J Cardiol       Date:  2022-01       Impact factor: 1.596

3.  Ablation index-guided 50W radiofrequency ablation for left atrial posterior wall isolation in atrial fibrillation.

Authors:  Wern Yew Ding; Lilith Tovmassian; Cedric Bierme; Nikola Kozhuharov; Richard L Snowdon; Dhiraj Gupta
Journal:  Indian Pacing Electrophysiol J       Date:  2022-05-26

4.  Rationale and study design for ablation of paroxysmal atrial fibrillation guided by ablation index: a multi-center, prospective randomized trial (PAF-AI trial).

Authors:  Ruhong Jiang; Minglong Chen; Jie Fan; Fu Yi; Anli Tang; Xingpeng Liu; Wenqing Zhu; Shaowen Liu; Xiaobo Huang; Weizhu Ju; Xi Zhang; Jie Li; Jiangui He; Liang Shi; Genqing Zhou; Yuegang Wang; Chenyang Jiang
Journal:  J Interv Card Electrophysiol       Date:  2020-05-11       Impact factor: 1.900

5.  Optimizing Durability in Radiofrequency Ablation of Atrial Fibrillation.

Authors:  Zain I Sharif; E Kevin Heist
Journal:  J Innov Card Rhythm Manag       Date:  2021-05-15

Review 6.  Efficiency, Safety, and Efficacy of High-Power Short-Duration Radiofrequency Ablation in Patients with Atrial Fibrillation.

Authors:  Xuerong Sun; Jiang Lu; Jinxuan Lin; Tianjie Feng; Ni Suo; Lihui Zheng; Zhimin Liu; Gang Chen; Xiaohan Fan; Shu Zhang; Guodong Niu
Journal:  Cardiol Res Pract       Date:  2021-02-15       Impact factor: 1.866

7.  Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study.

Authors:  Roland Richard Tilz; Makoto Sano; Julia Vogler; Thomas Fink; Roza Saraei; Vanessa Sciacca; Bettina Kirstein; Huong-Lan Phan; Sascha Hatahet; Lisbeth Delgado Lopez; Anna Traub; Charlotte Eitel; Michael Schlüter; Karl-Heinz Kuck; Christian-Hendrik Heeger
Journal:  Int J Cardiol Heart Vasc       Date:  2021-07-26

8.  Safety and Efficacy of High Power Shorter Duration Ablation Guided by Ablation Index or Lesion Size Index in Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.

Authors:  Xing Liu; Chun Gui; Weiming Wen; Yan He; Weiran Dai; Guoqiang Zhong
Journal:  J Interv Cardiol       Date:  2021-06-02       Impact factor: 2.279

9.  Fluoroless and contrast-free catheter ablation without a lead apron in routine clinical practice.

Authors:  Takumi J Matsubara; Katsuhito Fujiu; Yu Shimizu; Tsukasa Oshima; Jun Matsuda; Hiroshi Matsunaga; Gaku Oguri; Eriko Hasumi; Toshiya Kojima; Issei Komuro
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

10.  A prospective multi-site registry of real-world experience of catheter ablation for treatment of symptomatic paroxysmal and persistent atrial fibrillation (Real-AF): design and objectives.

Authors:  Allyson L Varley; Omar Kreidieh; Brigham E Godfrey; Carolyn Whitmire; Susan Thorington; Benjamin D'Souza; Steven Kang; Shrinivas Hebsur; Bipin K Ravindran; Edwin Zishiri; Brett Gidney; Matthew B Sellers; David Singh; Tariq Salam; Mark Metzl; Alex Ro; Jose Nazari; Westby G Fisher; Alexandru Costea; Anthony Magnano; Saumil Oza; Gustavo Morales; Anil Rajendra; Joshua Silverstein; Paul C Zei; Jose Osorio
Journal:  J Interv Card Electrophysiol       Date:  2021-07-02       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.